Research — APO Research, Inc.

Pharma & Healthcare

HER2 ADC Drugs

Types: RC48（Disitamab vedotin） · T-DM1（Kadcyla，Trastuzumab emtansine） · T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
Applications: Hospitals · Clinic · Others

5 editions27 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: HER2 ADC Drugs Compare research options for HER2 ADC Drugs

Pharma & Healthcare

Mebeverine

Types: Capsule · Tablet
Applications: On-line · Drug Store · Hospital

5 editions19 December 2025

View 5 research editions

$3,950Single user · USD · Market StructureExplore product: Mebeverine Compare research options for Mebeverine

Pharma & Healthcare

Immune Checkpoint Blockers

Types: Anti-PD-L1 Drug · Anti-PD-1 Drug · CTLA4
Applications: Blood Cancers · BreastCancer · Prostate Cancer

5 editions23 December 2025

View 5 research editions

$2,950Single user · USD · Industry ResearchExplore product: Immune Checkpoint Blockers Compare research options for Immune Checkpoint Blockers

Pharma & Healthcare

Dorzolamide Hydrochloride

Types: On-Line · Drug Store · Hospital
Applications: Pediatric Use · Geriatric Use · Pregnancy

5 editions19 December 2025

View 5 research editions

$3,950Single user · USD · Market StructureExplore product: Dorzolamide Hydrochloride Compare research options for Dorzolamide Hydrochloride

Pharma & Healthcare

Hydroxyapatite Microsphere Filler for Injection

Types: 50mg · 250mg · 100mg
Applications: Face Filling · Soft Tissue Repair and Filling · Other

5 editions27 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Hydroxyapatite Microsphere Filler for Injection Compare research options for Hydroxyapatite Microsphere Filler for Injection

Pharma & Healthcare

Glucagon-like peptide-1 (GLP-1) drugs are peptide therapeutics that mimic or potentiate the actions of endogenous GLP-1 at the GLP-1 receptor, a class-B G-protein–coupled receptor expressed on pancreatic islet cells, in the gastrointestinal tract, and in the central and cardiovascular systems. Pharmacologically they restore or amplify the physiologic “incretin effect”: in hyperglycaemic states they enhance glucose-dependent insulin secretion from β-cells, suppress…

Types: Short-acting · Long-acting
Applications: T2D · CV risk · Obesity

5 editions21 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: GLP-1 Drug Compare research options for GLP-1 Drug

Pharma & Healthcare

Muscle Relaxant Drug

Types: Centrally Acting Muscle Relaxants · Peripherally Acting Muscle Relaxants
Applications: Retail Pharmacy · Online Pharmacy · Hospital Pharmacy

5 editions19 December 2025

View 5 research editions